- Investing Ideas
- /
- Pharmaceuticals & Biotech Managed Healthcare
Pharmaceuticals & Biotech Managed Healthcare
Results
1273
0 new
US companies operating in the health insurance space
1,273 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
QGEN | US$45.02 | -1.3% | 10.0% | US$9.8b | US$50.97 | PE137.6x | E37.1% | n/a | ||
BIO | US$332.10 | -3.6% | -6.7% | US$8.9b | US$380.17 | PS3.6x | E51.6% | n/a | ||
ASND | US$147.36 | -4.0% | 55.2% | US$8.7b | US$193.94 | PS24.7x | E67.9% | n/a | ||
ROIV | US$11.57 | -2.9% | -7.8% | US$8.7b | US$16.94 | PE1.8x | E-55.6% | n/a | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | ||
LEGN | US$46.85 | -7.8% | -30.4% | US$8.0b | US$82.98 | PS18.9x | E63.7% | n/a | ||
ITCI | US$73.21 | -4.9% | 36.1% | US$7.9b | US$96.13 | PS13.7x | E64.4% | n/a | ||
RGEN | US$147.18 | 1.0% | -8.1% | US$7.8b | US$193.82 | PS13.7x | E85.3% | n/a | ||
TEM | US$51.87 | 3.6% | n/a | US$7.6b | US$46.00 | PS13.4x | E61.5% | n/a | ||
RVMD | US$43.86 | -5.0% | 55.3% | US$7.5b | US$59.21 | PS9873.8x | E12.8% | n/a | ||
EXEL | US$26.24 | -2.2% | 17.2% | US$7.4b | US$27.60 | PE21.4x | E15.7% | n/a | ||
NUVL | US$101.05 | -2.1% | 117.0% | US$7.1b | US$111.27 | PB11.2x | E2.5% | n/a | ||
HALO | US$56.95 | -4.3% | 45.5% | US$7.1b | US$61.10 | PE21.4x | E22.0% | n/a | ||
VKTX | US$62.32 | -8.6% | 455.4% | US$7.0b | US$109.70 | PB7.5x | E1.6% | n/a | ||
ELAN | US$13.73 | -8.9% | 22.7% | US$6.8b | US$18.63 | PS1.5x | E73.7% | n/a | ||
JAZZ | US$110.19 | -1.0% | -15.9% | US$6.7b | US$178.78 | PE17.2x | E20.1% | n/a | ||
IONS | US$41.10 | -3.8% | -11.2% | US$6.5b | US$62.67 | PS8x | E34.7% | n/a | ||
CYTK | US$52.63 | -5.3% | 70.9% | US$6.2b | US$81.29 | PS1975.9x | E43.1% | n/a | ||
STVN | US$20.82 | 4.8% | -29.6% | US$5.5b | US$26.99 | PE41.5x | E18.3% | 0.3% | ||
ABCM | US$23.99 | 0.08% | 54.7% | US$5.5b | US$23.66 | PE1758.5x | E39.3% | 0% | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
BPMC | US$89.06 | -2.1% | 74.4% | US$5.5b | US$127.35 | PS15.6x | E67.4% | n/a | ||
RNA | US$42.17 | -7.6% | 542.8% | US$5.4b | US$66.09 | PS466x | E25.5% | n/a | ||
RARE | US$55.22 | -6.1% | 57.0% | US$5.2b | US$90.00 | PS10.6x | E50.7% | n/a |